Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
BRUKER CORP incurred senior notes of CHF 50 million aggregate principal amount of 2.60% Series A Senior Notes due April 15, 2036 and CHF 50 million aggregate with institutional accredited investors named therein at 2.60% and 2.62% maturing April 15, 2036 and April 15, 2039.
- Instrument
- senior notes
- Principal
- CHF 50 million aggregate principal amount of 2.60% Series A Senior Notes due April 15, 2036 and CHF 50 million aggregate
- Counterparty
- institutional accredited investors named therein
- Rate
- 2.60% and 2.62%
- Maturity
- April 15, 2036 and April 15, 2039
- Event
- incurrence
Exact text from the filing
On February 8, 2024, Bruker Corporation (the “Company”) entered into a note purchase agreement among the Company and the institutional accredited investors named therein (the “Note Purchase Agreement”), pursuant to which the Company will issue and sell (i) CHF 50 million aggregate principal amount of 2.60% Series A Senior Notes due April 15, 2036 (the “Series A Notes”) and (ii) CHF 50 million aggregate principal amount of its 2.62% Series B Senior Notes due April 15, 2039 (the “Series B Notes” together with the Series A Notes, the “Notes”)
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
BRUKER CORP entered into Note Purchase Agreement with unknown valued at Not specified in excerpt (effective 2024-02-12).
- Action
- entry
- Agreement
- notes offering
- Value
- Not specified in excerpt
- Effective
- 2024-02-12
Exact text from the filing
Terms used in this Item 1.01 and not otherwise defined herein have the meanings given to them in the Note Purchase Agreement. Interest on the Notes is payable semi-annually on April 15 and October 15 of each year, commencing April 15 or October 15, 2024. The Notes are unsecured obligations of the Company and are fully and unconditionally guaranteed by certain of the Company’s subsidiaries.
View on SEC.gov